Efficacy and safety of mesenchymal stem cell-derived microvesicles in mouse inflammatory arthritis
Open Access
- 25 March 2024
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 131, 111845
Abstract
No abstract availableKeywords
Funding Information
- National Key Research and Development Program of China
- Sichuan University
- West China Hospital of Sichuan University (2016YFC0906201)
This publication has 49 references indexed in Scilit:
- Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19Frontiers of Medicine, 2020
- Mesenchymal Stem Cells Reduce Corneal Fibrosis and Inflammation via Extracellular Vesicle-Mediated Delivery of miRNAStem Cells Translational Medicine, 2019
- Human umbilical cord mesenchymal stem cell‐derived extracellular vesicles: A novel therapeutic paradigmJournal of Cellular Physiology, 2019
- Interaction between mesenchymal stromal cell‐derived extracellular vesicles and immune cells by distinct protein contentJournal of Cellular Physiology, 2018
- Darvadstrocel: A Review in Treatment-Refractory Complex Perianal Fistulas in Crohn’s DiseaseBioDrugs, 2018
- Immunomodulatory Behavior of Mesenchymal Stem Cells2018
- Navigating Market Authorization: The Path Holoclar Took to Become the First Stem Cell Product Approved in the European UnionStem Cells Translational Medicine, 2017
- Mesenchymal Stem Cell-Derived Microvesicles Modulate Lipopolysaccharides-Induced Inflammatory Responses to Microglia CellsStem Cells, 2017
- Extracellular vesicles for drug deliveryAdvanced Drug Delivery Reviews, 2016
- Tissue factor triggers procoagulation in transplanted mesenchymal stem cells leading to thromboembolismBiochemical and Biophysical Research Communications, 2013